Legal Opinion
Jilin Henghe Pharmaceutical Co. v. United States
United States Court of International Trade
Decided June 29, 2004No. SLIP OP. 04-77; Court 04-00151PublishedCited by 7 opinions
1Opinion of the Court
OPINION
POGUE, Judge.
In this action, Plaintiffs Jilin Henghe Pharmaceutical Co. and Jilin Pharmaceutical USA (“Jilin”) challenge the validity of liquidation 1 instructions issued by the United States Department of Commerce (“Commerce”) to the United States Bureau of Customs and Border Protection (“Customs”) 2 regarding Jilin’s entries of bulk aspirin from China.
Before the Court is Plaintiffs’ motion requesting mandamus relief, which the parties have agreed to treat as a motion for declaratory relief. Defendant has filed a motion to dismiss, alleging a lack of subject matter jurisdiction, that…
2Cases cited9 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- United States v. Mead Corp.Supreme Court of the United States · 2001
- Doran v. Salem Inn, Inc.Supreme Court of the United States · 1975
- Consolidated Bearings Company, Plaintiff-Cross v. United StatesCourt of Appeals for the Federal Circuit · 2003
- Shinyei Corporation of America v. United StatesCourt of Appeals for the Federal Circuit · 2004
4 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Autoalliance International, Inc. v. United StatesUnited States Court of International Trade · 2005
- Andaman Seafood Co., Ltd v. United StatesUnited States Court of International Trade · 2010
- Snap-on, Inc. v. United StatesUnited States Court of International Trade · 2013
- Perry Chem. Corp. v. United StatesUnited States Court of International Trade · 2019
- Andaman Seafood Co. v. United StatesUnited States Court of International Trade · 2010
2 more not listed; retrieve them via the Exa API.